Lawsuit Overview
October 23, 2020 - An investor in shares of Innate Pharma S.A. (NASDAQ: IPHA) filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by Innate Pharma S.A. in connection with certain allegedly false and misleading statements made between March 10, 2020 and September 8, 2020. France based Innate Pharma S.A., ...
You must register (for free) or login to view the entire case.